Study to Evaluate the Safety and Efficacy of Aceneuramic Acid Extended-Release (Ace-ER) Tablets in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)

Clinical trial NCT02736188 · TERMINATED

Trial details

NCT number: NCT02736188
Sponsor: Ultragenyx Pharmaceutical Inc
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Hereditary Inclusion Body Myopathy Distal Myopathy With Rimmed Vacuoles Distal Myopathy, Nonaka Type GNE Myopathy Quadriceps Sparing Myopathy

Start date: 2016-05-02
Primary completion: 2018-01-10
Enrollment: 143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.